Pharmacology and Pharmacokinetics of Danazol

References Agarwal, M.K. and Coupry, F.: Antiglyconeogenic activity of gonadal steroid analogues in relation to liver glucocorticoid-receptor binding. FEBS Utters 82: 172–174 (1977). Andrews, M.C. and Wentz, A.C.: The effects of danazol on gonadotropins and steroid blood levels in normal and anovulatory women. American Journal of Obstetrics and Gynecology 121: 817–828 (1975). Asch, R.H.; Fernandez, E.O.; Smith, C.G.; Siler-Khodr, T.M. and Pauerstein, C.J.: Effects of danazol on gonadotropin levels in castrated rhesus monkeys. Obstetrics and Gynecology 53: 415–421 (1979). Barbieri, R.L.; Canick, J.A.; Makris, A.; Todd, R.B.; Davies, I.J. and Ryan, K.J.: Danazol inhibits steroidogenesis. Fertility and Sterility 28: 809–813 (1977a). Barbieri, R.L.; Canick, J.A. and Ryan, K.J.: Danazol inhibits steroidogenesis in the rats testis in vitro. Endocrinology 101: 1676–1682 (1977b). Barbieri, R.L.; Lee, H. and Ryan, K. J.: Danazol binding to rat androgen, glucocorticoid, progesterone, and estrogen receptors: Correlation with biologic activity. Fertility and Sterility 31: 182–186 (1979). Creange, J.E. and Potts, G.O.: A competitive radioligand assay for danazol using pregnant guinea pig plasma. Steroids 23: 411–420 (1974). Davison, C.; Banks, W. and Fritz, A.: The absorption, distribution and metabolic rate of Danazol in rats, monkeys, and human volunteers. Archives Internationales de Pharmacodynamie et de Therapie 221: 294–310 (1976). Dmowski, W.P.; Scholer, H.F.L.; Mahesh, V.B. and Greenblatt, R.B.: Danazol — a synthetic steroid derivative with interesting physiologic properties. Fertility and Sterility 22: 9–18 (1971). Eldridge, J.C.; Dmowski, W.P. and Mahesh, V.B.: Effects of castration of immature rats on serum FSH and LH, and of various steroid treatments after castration. Biology of Reproduction 10: 438–446 (1974). Franchimont, P. and Cramilion, C: The effect of danazol on anterior pituitary function. Fertility and Sterility 28: 814–817 (1977). Greenblatt, R.B.; Dmowski, W.P.; Mahesh, V.B. and Scholer, H.: Clinical studies with an antigonadotropin — danazol. Fertility and Sterility 22: 102–112 (1971). Hanzlik, P.J.; Lehman, A.J.; Van Winkle, W. and Kennedy, N.K.: General metabolic and glycogenic actions of propylene glycol and some other glycols. Journal of Pharmacology and Experimental Therapeutics 67: 114–126 (1939). Jones, R.C. and Edgren, R.A.: The effects of various steroids on the vaginal histology in the rat. Fertility and Sterility 24: 284–291 (1973). Kasuya, Y. and Wolff, M.E.: Uptake of androgen analogs by prostate tissue. Journal of Medicinal Chemistry 16: 832–839 (1973). Klein, M. and Parkes, A.S.: The progesterone-like action of testosterone and certain related compounds. Royal Society of London Proceeding, Series B 121: 574–579 (1937). Manson, A.J., Stonner, F.W.; Neuman, A.C.; Christiansen, R.G.; Clarke, R.L.; Ackerman, J.H.; Page, D.F.; Dean, J.W.; Phillips, D.K.; Potts, G.O.; Arnold, A.; Beyler, A.L. and Clinton, R.O.: Steroidal heterocycles. VIII. Androstano [2, 3-d] isoxazoles and related compounds. Journal of Medicinal Chemistry 6: 1–9 (1963). Pedroza, E.; Vilches-Martinez, J.A.; Arimura, A. and Schally, A. V.: Danazol effects on gonadotropin basal levels and pituitary responsiveness to LH-RH in immature male rats. Contraception 17: 61–69 (1978). Peterson, J.E.; King, M.E.; Banks, W.F.; Baker, J.F.; Jenson, A.F.; Ross, R.W. Jr.; Clemans, S. and Edelson, J.: Radioimmunoassay for danazol in human and monkey plasma. Journal of Phamaceutical Sciences 67(10): 1425–1428 (1978). Potts, G.O.: Experimental Pharmacology of Danazol, Proceedings of a Symposium on Recent Advances in Endometriosis. International Congress Series No. 368: 68–86 (1976). Potts, G.O.: Pharmacology of Danazol, Abstracts and Proceedings of a Symposium. Excerpta Medica: 47–48 (1977a). Potts, G.O.: Pharmacology of Danazol, Proceeding of a Symposium on Danol (Danazol). Journal of International Medical Research 5: 1–14 (1977b). Potts, G.O.; Beyler, A.L. and Schane, H.P.: Pituitary gonadotropin inhibitory activity of danazol. Fertility and Sterility 25: 367–372 (1974). Schane, H.P. and Potts, G.O.: Oral contraceptive activity of danazol in the rhesus monkey. Fertility and Sterility 25: 363–366 (1974). Sherins, R.J.; Gandy, H.M.; Thorslund, T.W. and Paulsen, C.A.: Pituitary and testicular function studies. I. Experience with a new gonadal inhibitor, 17α-pregn-4-en-20-yno-(2,3-d)isoxazol-17-ol (danazol). Journal of Clinical Endocrinology and Metabolism 32: 522–531 (1971). Wentz, A.C.; Jones, G.S.; Sapp, K.C. and King, T.M.: Progestational activity of danazol in the human female subject. American Journal of Obstetrics and Gynecology 126: 378–384 (1976). Williams, T.A.; Edelson, J. and Ross, R.W. Jr.: A radioimmunoassay for danazol. Steroids 3m: 206–217 (1978). Wood, G.P.; Wu, G.J.; Flickinger, G.L. and Mikhail, G.: Hormonal changes associated with danazol therapy. Obstetrics and Gynecology 45: 302–304 (1975). Author information Authors and Affiliations Rights and permissions About this article Cite this article Potts, G.O., Schane, H.P. & Edelson, J. Pharmacology and Pharmacokinetics of Danazol. Drugs 19, 321–330 (1980). https://doi.org/10.2165/00003495-198019050-00001 Published: Issue date: DOI: https://doi.org/10.2165/00003495-198019050-00001